Sickle Cell Disease, SCD
Showing 1 - 25 of >10,000
Sickle Cell Disease Trial in Memphis (Plerixafor)
Recruiting
- Sickle Cell Disease
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 11, 2023
Genetic and Haematological Modifiers of SCD Severity in Kaduna
Not yet recruiting
- Sickle Cell Disease
- (no location specified)
Apr 27, 2023
Sickle Cell Disease Trial in Marseille (NUV001)
Not yet recruiting
- Sickle Cell Disease
- NUV001
-
Marseille, FranceAphm Hopital La Timone Adultes Sce Medecine Interne (Umap)
Mar 28, 2023
SCD Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-Invasive Infrared Spectroscopy)
Recruiting
- SCD
- Non-Invasive Infrared Spectroscopy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Cardiovascular Diseases, Sickle Cell Disease, Exercise Trial in Birmingham (Accelerometer)
Withdrawn
- Cardiovascular Diseases
- +2 more
- Accelerometer
- (no location specified)
Oct 17, 2022
Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)
Not yet recruiting
- Sickle Cell Disease
- Motixafortide
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 8, 2022
Sickle Cell Disease Trial in Durham (AB1)
Not yet recruiting
- Sickle Cell Disease
-
Durham, North CarolinaDuke University Medical Center
Jul 21, 2022
Sickle Cell Disease Trial (open-label GBT021601)
Not yet recruiting
- Sickle Cell Disease
- open-label GBT021601
- (no location specified)
Nov 21, 2022
Sickle Cell Disease, Hyperbaric Oxygen Therapy, Vaso-occlusive Crisis Trial in Geneva (HBOT in Hyperbaric chamber, Hyperbaric
Recruiting
- Sickle Cell Disease
- +2 more
- HBOT in Hyperbaric chamber
- Hyperbaric chamber for placebo
-
Lyon, France
- +2 more
Nov 1, 2022
Sickle Cell Disease, Sickle Cell Anemia, Insomnia Trial run by the National Cancer Institute (NCI) (ACT Intervention, Waitlist)
Not yet recruiting
- Sickle Cell Disease
- +6 more
- ACT Intervention
- Waitlist
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Sickle Cell Disease Trial (Positron Emission Tomography, Cu-64]-LLP2A)
Recruiting
- Sickle Cell Disease
- Positron Emission Tomography
- Cu-64]-LLP2A
-
Pittsburgh, PennsylvaniaUPMC
Dec 2, 2022
Sickle Cell Disease, Vaso-occlusive Crisis Trial in Rouen (Erythrocytic parameters and thrombin generation assay measurement)
Recruiting
- Sickle Cell Disease
- Vaso-occlusive Crisis
- Erythrocytic parameters and thrombin generation assay measurement
-
Rouen, FranceRouen university Hospital
May 17, 2022
Sickle Cell Disease Trial in Little Rock (GBT021601)
Recruiting
- Sickle Cell Disease
-
Little Rock, ArkansasLynn Institute of the Ozarks
Aug 10, 2022
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)
Recruiting
- Sickle Cell Disease
- Allogeneic Non-Myeloablative Stem Cell Transplantation
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Feb 16, 2022
Sickle Cell Disease Trial in Atlanta, Cincinnati (I-STRONG for SCD)
Recruiting
- Sickle Cell Disease
- I-STRONG for SCD
-
Atlanta, Georgia
- +1 more
Oct 26, 2023
Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral
Recruiting
- Congenital Hemolytic Anemia
- Sickle Cell Disease
- Peripheral blood hematopoietic progenitor cell (PBPC) transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy Trial in Durham (SCD-specific COVID-19 vaccination information (SCVI)
Not yet recruiting
- Sickle Cell Disease
- +2 more
- SCD-specific COVID-19 vaccination information (SCVI) video
-
Durham, North CarolinaDuke Adult Sickle Cell Program
Aug 17, 2023
Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)
Recruiting
- Sickle Cell Disease
- OTQ923
-
Los Angeles, California
- +4 more
Jan 9, 2023
Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)
Active, not recruiting
- Sickle Cell Disease
- DREPAGLOBE drug product
-
Paris, FranceDepartment of Biotherapy, Necker-Enfants Malades Hospital
Sep 26, 2022
Sickle Acute Chest Syndrome UsingCombination of Plasma Bimarkers
Completed
- Sickle Cell Disease (SCD)
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Aug 17, 2022